New type of retinal prosthesis could better restore sight to blind, Stanford study says
May 12, 2012 by admin · Leave a Comment
Using tiny solar-panel-like cells surgically placed underneath the retina, scientists at the Stanford University School of Medicine have devised a system that may someday restore sight to people who have lost vision because of certain types of degenerative eye diseases.
Study shows benefit of new maintenance therapy for multiple myeloma
May 10, 2012 by admin · Leave a Comment
Multiple myeloma is a form of cancer where the plasma cells in the bone marrow grow out of control, causing damage to bones as well as predisposing patients to anemia, infection and kidney failure. A medical procedure called autologous hematopoietic stem cell transplantation, commonly known as a stem cell transplant, is frequently an important treatment option for many patients.
Vitamin K2: New hope for Parkinson’s patients?
May 10, 2012 by admin · Leave a Comment
Neuroscientist Patrik Verstreken, associated with VIB and KU Leuven, succeeded in undoing the effect of one of the genetic defects that leads to Parkinson’s using vitamin K2. His discovery gives hope to Parkinson’s patients. This research was done in collaboration with colleagues from Northern Illinois University (US) and will be published this evening on the website of the authorative journal Science.
Discovery in cell signaling could help fight against melanoma
May 9, 2012 by admin · Leave a Comment
The human body does a great job of generating new cells to replace dead ones but it is not perfect. Cells need to communicate with or signal to each other to decide when to generate new cells. Communication or signaling errors in cells lead to uncontrolled cell growth and are the basis of many cancers.
Culprit responsible for severe systemic scleroderma complications in African-Americans found
A new analysis finds that compared to Caucasians, African-Americans with systemic scleroderma have more antibodies in the blood that are linked to severe complications and an increased likelihood of death. They say this finding, published today in Arthritis & Rheumatism, suggests physicians can use these disease markers to screen and treat scleroderma patients proactively.
Response to first drug treatment may signal likelihood of future seizures in people with epilepsy
May 8, 2012 by admin · Leave a Comment
In a study published in Neurology®, the medical journal of the American Academy of Neurology, Professor Kwan, who is also head of the clinical epilepsy program at the Royal Melbourne Hospital and an international authority in antiepileptic drug development, believes a pattern emerges in the early stages.
NTU scientists invent superbug killers
May 8, 2012 by admin · Leave a Comment
Conceived at Nanyang Technological University (NTU), it comes in the form of a coating which has a magnetic-like feature that attracts bacteria and kills them without the need for antibiotics.
Discovery of a new family of key mitochondrial proteins for the function and viability of the brain
May 8, 2012 by admin · Leave a Comment
A team headed by Eduardo Soriano at the Institute for Research in Biomedicine (IRB Barcelona) has published a study in Nature Communications describing a new family of six genes whose function regulates the movement and position of mitochondria in neurons. Many neurological conditions, including Parkinson’s and various types of Charcot-Marie-Tooth disease, are caused by alterations of genes that control mitochondrial transport, a process that provides the energy required for cell function.
Non-drug depression treatment rapidly and significantly improves disease symptoms and QoL
May 7, 2012 by admin · Leave a Comment
New data released today at the annual meeting of the American Psychiatric Association show that patients with unipolar, non-psychotic Major Depressive Disorder (MDD) receiving transcranial magnetic stimulation (TMS) with NeuroStar TMS Therapy® achieved significant improvements in both depression symptoms and in quality of life measurements. Overall, 58 percent of patients achieved a positive response to NeuroStar TMS therapy, with 37 percent of patients achieving remission from their depression.
Flavonoid compound found in foods and supplements shown to prevent the formation of blood clots
May 7, 2012 by admin · Leave a Comment
A compound called rutin, commonly found in fruits and vegetables and sold over the counter as a dietary supplement, has been shown to inhibit the formation of blood clots in an animal model of thrombosis.
